Legend Biotech Corporation vs Pfizer, Inc. — Stock Comparison

LEGN
Legend Biotech Corporation
$23.59
▲ 0.30%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 5.9/10

Q·Score Breakdown

5.9
Neutral
Overall
6.5
Neutral
0.2
Quality
7.4
7.6
Health
7
5.5
Growth
5.6
9.7
Valuation
6.7
8.3
Sentiment
5.2
LEGN

Consensus analyst target of $57.23 is 143% above current price.

currently unprofitable (-29% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $57.23 (+142.6%)
16 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

LEGN
PFE
Trailing P/E
19.4×
20.5×
Forward P/E
9.4×
-28.8%
Profit Margin
12.4%
20.0%
Gross Margin
75.8%
-29.1%
ROE
8.9%
64.2%
Revenue Growth
-1.2%
Earnings Growth
0.08
Beta
0.39
Price / Book
$4.4B
Market Cap
$149.8B
$16 – $45
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →